Total Funding
38
Total FundingDebt Financing raised
Growth Score in past quarter
pts
Heat Score 38 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
160637
Capillary Biomedical is a medical device startup developing technologies for diabetes management.
Acquired by 
Tandem Diabetes Care
- Douglas Muchmore: Senior Clinical Consultant
- Paul Strasma: President and CEO
About the Company
Capillary Biomedical is a medical device startup developing technologies for diabetes management. They aim to dramatically simplify glucose monitoring and insulin delivery, reducing the burden on both patients and the overall healthcare system. The company is based in Irvine, CA and is a spin-out of the Artificial Pancreas Center at the Sidney
Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA.
